Molecular Docking Evaluation of Syzygium aromaticum Isolated Compounds Against Exo-β-(1,3)-glucanases of Candida albicans

Mohammed H. F. Shalayel

Department of Pharmacy Practice, College of Pharmacy, University of Hafr Al-Batin, Hafr Al-Batin, Saudi Arabia.

Ghassab M. Al-Mazaideh *

Department of Pharmaceutical Chemistry, College of Pharmacy, University of Hafr Al-Batin, Hafr Al-Batin, Saudi Arabia.

Farhan Khashim Al Swailmi

Department of Pharmacy Practice, College of Pharmacy, University of Hafr Al-Batin, Hafr Al-Batin, Saudi Arabia.

Saleem Aladaileh

Department of Pharmacy Practice, College of Pharmacy, University of Hafr Al-Batin, Hafr Al-Batin, Saudi Arabia.

Saada Nour

University of Bahri, College of Medicine, Sudan.

Akef T. Afaneh

Department of Chemistry, Faculty of Science, Al-Balqa Applied University, P. O. Box 19117, Postal code 19117, Al-Salt, Jordan.

Ali Marashdeh

Department of Chemistry, Faculty of Science, Al-Balqa Applied University, P. O. Box 19117, Postal code 19117, Al-Salt, Jordan.

*Author to whom correspondence should be addressed.


Abstract

Seventeen compounds from Syzygium aromaticum are selected for exo-β-(1,3)-glucanases inhibitory activity by using molecular docking study. The compounds are uploaded from the PubChem database and molecular docking with AutoDock 1.5.6 tools is carried out. The molecular docking scores indicate that stigmasterol and campesterol are of the highest potentials, and approximately have similar binding affinities with Candida albicans' active site (3N9K, 3O6A). The hydroxyl moiety has played an important role in the antifungal potentiality of all studied compounds.

Keywords: Candida albicans, syzygium aromaticum, exo-β-(1,3)-glucanases, stigmasterol, campesterol.


How to Cite

Shalayel, Mohammed H. F., Ghassab M. Al-Mazaideh, Farhan Khashim Al Swailmi, Saleem Aladaileh, Saada Nour, Akef T. Afaneh, and Ali Marashdeh. 2021. “Molecular Docking Evaluation of Syzygium Aromaticum Isolated Compounds Against Exo-β-(1,3)-Glucanases of Candida Albicans”. Journal of Pharmaceutical Research International 32 (46):34-44. https://doi.org/10.9734/jpri/2020/v32i4631100.

Downloads

Download data is not yet available.